8,402,106 Shares in Sotera Health Company $SHC Purchased by Jupiter Topco LLC

Key Points

• Jupiter Topco LLC acquired 8.4 million Sotera Health shares worth approximately $149.1 million, giving it a 2.94% stake. Institutional investors collectively own 91.03% of the company.
• Company insiders have been selling shares: Chairman Michael Petras sold 850,000 shares and insider Michael Rutz sold 150,000 shares, while insiders sold approximately $24 million worth of stock over the past 90 days.
• Sotera Health reported quarterly EPS of $0.26, beating estimates by $0.02, while revenue rose 9.2% year over year to $321.4 million. Analysts maintain a “Moderate Buy” consensus with an average price target of $21.50.

Jupiter Topco LLC bought a new position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 8,402,106 shares of the company's stock, valued at approximately $149,137,000. Jupiter Topco LLC owned 2.94% of Sotera Health at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. IFP Advisors Inc grew its holdings in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company's stock valued at $26,000 after purchasing an additional 1,371 shares in the last quarter. Rothschild Investment LLC purchased a new stake in Sotera Health during the fourth quarter worth approximately $27,000. Meeder Asset Management Inc. acquired a new position in shares of Sotera Health in the 2nd quarter valued at $37,000. Root Financial Partners LLC lifted its holdings in shares of Sotera Health by 217.5% in the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company's stock valued at $30,000 after purchasing an additional 1,455 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new stake in shares of Sotera Health in the fourth quarter valued at approximately $40,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Michael P. Rutz sold 150,000 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the transaction, the insider owned 334,279 shares in the company, valued at $6,297,816.36. This trade represents a 30.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the firm's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the transaction, the chairman owned 3,969,393 shares of the company's stock, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. Insiders own 15.36% of the company's stock.

Analyst Ratings Changes

Several research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on Sotera Health from $16.00 to $18.00 and gave the company a "neutral" rating in a research note on Friday, August 7th. UBS Group set a $19.00 target price on shares of Sotera Health in a report on Wednesday, June 24th. Citigroup boosted their price target on Sotera Health from $23.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, August 7th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research note on Friday, June 5th. They set a "buy" rating and a $20.00 price target on the stock. Finally, Weiss Ratings raised shares of Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Sotera Health has a consensus rating of "Moderate Buy" and a consensus price target of $21.50.

Sotera Health Stock Up 0.2%

SHC stock opened at $19.54 on Thursday. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. Sotera Health Company has a fifty-two week low of $13.09 and a fifty-two week high of $19.85. The firm's 50-day simple moving average is $17.98 and its 200 day simple moving average is $16.38. The stock has a market cap of $5.58 billion, a PE ratio of 34.28 and a beta of 1.77.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm had revenue of $321.38 million for the quarter, compared to the consensus estimate of $309.70 million. During the same quarter in the previous year, the business earned $0.20 EPS. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, sell-side analysts predict that Sotera Health Company will post 0.86 EPS for the current year.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source